Walleye Trading LLC Pfizer Inc Call Options Transaction History

Walleye Trading LLC

$46.3 Billion
Q1 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $7.12 Million - $8.18 Million	-275,200 Reduced 27.37%	730,300 $20.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $6.9 Million - $8.96 Million	264,000 Added 35.6%	1,005,500 $28.9 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $14.6 Million - $17 Million	454,000 Added 157.91%	741,500 $24.6 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $16.8 Million - $19.4 Million	-465,300 Reduced 61.81%	287,500 $10.5 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $2.61 Million - $3.4 Million	66,300 Added 9.66%	752,800 $30.7 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $9.91 Million - $12.9 Million	237,400 Added 52.86%	686,500 $35.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $3.26 Million - $3.98 Million	74,500 Added 19.89%	449,100 $19.7 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $1.09 Million - $1.29 Million	23,400 Added 6.66%	374,600 $19.6 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $6.48 Million - $8.03 Million	141,600 Added 67.56%	351,200 $18.2 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $144,620 - $214,375	-3,500 Reduced 1.64%	209,600 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $7.44 Million - $9.56 Million	189,600 Added 806.81%	213,100 $9.17 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $750,518 - $850,212	20,900 Added 803.85%	23,500 $920,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $257,873 - $290,829	-7,700 Reduced 74.76%	2,600 $94,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $1.88 Million - $2.4 Million	-56,300 Reduced 84.53%	10,300 $379,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $4.48 Million - $5.26 Million	-141,200 Reduced 67.95%	66,600 $2.44 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $4.12 Million - $5 Million	-136,900 Reduced 39.72%	207,800 $6.8 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $8.9 Million - $12.7 Million	329,100 Added 2109.62%	344,700 $11.3 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $2.44 Million - $2.76 Million	-74,000 Reduced 82.59%	15,600 $611,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $510,093 - $661,441	-15,700 Reduced 14.91%	89,600 $3.22 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $10.3 Million - $11.6 Million	-279,800 Reduced 72.66%	105,300 $4.56 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $10.6 Million - $11.7 Million	283,000 Added 277.18%	385,100 $16.4 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $4.2 Million - $4.79 Million	-109,100 Reduced 51.66%	102,100 $4.46 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $3.56 Million - $4.32 Million	-103,300 Reduced 32.85%	211,200 $9.31 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $5.39 Million - $5.74 Million	163,300 Added 108.0%	314,500 $11.4 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $95,730 - $111,060	3,000 Added 2.02%	151,200 $5.37 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $2.39 Million - $2.53 Million	71,800 Added 93.98%	148,200 $5.37 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $7.02 Million - $7.73 Million	-226,500 Reduced 74.78%	76,400 $2.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	302,900	302,900 $10.2 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account